A meta-analysis concluded that GLP-1 RA, regardless of structural homology, reduced the risk of individual major adverse cardiovascular event components, all-cause mortality, hospital admission for heart failure, and worsening kidney function in patients with type 2 diabetes [36]. The gene discussed is GLP1R; the disease is type 2 diabetes mellitus.